Liver Diseases  >>  Advaferon (interferon alfacon-1)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Advaferon (interferon alfacon-1) / Astellas, Sanofi
NCT00266318: Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Completed
4
40
US
Interferon Alfacon-1 and Ribavirin
Beth Israel Medical Center, InterMune
Hepatitis C
05/07
05/07
ENHANCE, NCT00456248: Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

Terminated
4
5
US
Infergen and ribavirin
Kadmon Corporation, LLC
Hepatitis C
10/07
10/07
NCT00207402: Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Completed
4
34
US
rosiglitazone, Infergen (interferon alfacon-1), Avandia (rosiglitazone), Ribavirin
Brooke Army Medical Center, InterMune
Hepatitis C
01/10
07/10

Download Options